Vestibular Schwannoma Clinical Trial
— ReveSTANOfficial title:
Assessment of the Preoperative Vestibular Rehabilitation Effectiveness on Balance Control Compensation After Vestibular Schwannoma Surgery
Vestibular schwannoma (VS) is a benign tumour from Schwann cells surrounding the vestibular
nerve, which slowly grows within the internal auditory canal and then into the
cerebellopontine angle, leading to a gradual vestibular dysfunction. The slowly progressive
alteration of vestibular function allows the gradual implementation of central adaptive
mechanisms called vestibular compensation. The total unilateral vestibular deafferentation
induced by the surgical tumour removal suddenly leads to a decompensation of this previously
compensated situation, which explains why most patients report severe vertigo immediately
after surgery and which is responsible for perturbations of the postural control
(Parietti-Winkler et al., 2006, 2008, 2010, 2011). Recently, Gauchard et al. (2013)
suggested that preoperative and regular physical activity would limit the adverse effects of
surgical removal on balance control. Also, patients benefited faster and better from the
postoperative vestibular rehabilitation.
Thus, preoperative vestibular rehabilitation, including physical and balance exercises,
could help to limit postoperative balance disorders and promote postoperative balance
compensation. This could lead to a decrease in the duration and cost of the postoperative
management and faster improvement of quality of life.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | April 2019 |
Est. primary completion date | April 2018 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Patients with unilateral vestibular schwannoma (stage I to IV according to the Koos classification) with an indication for surgery. - Patients gave their written informed consent - Patients are affiliated to the french social welfare Exclusion Criteria: - Disorders from the motor and/or somesthetic systems (especially the lower limbs) - Contraindications to the scheduled functional assessments: ear pathology different from vestibular schwannoma such as cholesteatoma of the middle ear, tympanic membrane perforation, etc. - Refusal of the surgical procedure |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
France | University Hospital of Nancy | Nancy |
Lead Sponsor | Collaborator |
---|---|
Central Hospital, Nancy, France | University of Lorraine |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Acute balance compensation | Change in composite equilibrium score from baseline to 8 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA). Comparison between both groups (preoperative rehabilitation vs. usual). |
One week after surgery | No |
Secondary | Balance compensation at short term | Change in composite equilibrium score from baseline to 30 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA). Comparison between both groups (preoperative rehabilitation vs. usual). |
One month after surgery | No |
Secondary | Balance compensation at middle term | Change in composite equilibrium score from baseline to 90 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA). Comparison between both groups (preoperative rehabilitation vs. usual). |
Three months after surgery | No |
Secondary | Balance compensation at long term | Change in composite equilibrium score from baseline to 365 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA). Comparison between both groups (preoperative rehabilitation vs. usual). |
One year after surgery | No |
Secondary | Preoperative balance compensation | Change in composite equilibrium score from baseline to three days before surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA). Comparison between both groups (preoperative rehabilitation vs. usual). |
From baseline to three days before surgery | No |
Secondary | Acute change in self-rated dizziness (measured with the Dizziness Handicap Inventory) | Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) from baseline to 8 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation. Comparison between both groups (preoperative rehabilitation vs. usual). |
One week after surgery | No |
Secondary | Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) at short term | Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) from baseline to 30 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation. Comparison between both groups (preoperative rehabilitation vs. usual). |
One month after surgery | No |
Secondary | Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) at middle term | Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) from baseline to 90 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation. Comparison between both groups (preoperative rehabilitation vs. usual). |
Three months after surgery | No |
Secondary | Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) at long term | Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) from baseline to 365 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation. Comparison between both groups (preoperative rehabilitation vs. usual). |
One year after surgery | No |
Secondary | Acute change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) | Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) from baseline to 8 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation. Comparison between both groups (preoperative rehabilitation vs. usual). |
One week after surgery | No |
Secondary | Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) at short term | Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) from baseline to 30 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation. Comparison between both groups (preoperative rehabilitation vs. usual). |
One month after surgery | No |
Secondary | Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) at middle term | Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) from baseline to 90 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation. Comparison between both groups (preoperative rehabilitation vs. usual). |
Three months after surgery | No |
Secondary | Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) at long term | Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) from baseline to 365 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation. Comparison between both groups (preoperative rehabilitation vs. usual). |
One year after surgery | No |
Secondary | Acute change in vestibular function | Change in vestibular function (measured by means of videonystagmography) from baseline to 8 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests. Comparison between both groups (preoperative rehabilitation vs. usual). |
One week after surgery | No |
Secondary | Change in vestibular function at short term | Change in vestibular function (measured by means of videonystagmography) from baseline to 30 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests. Comparison between both groups (preoperative rehabilitation vs. usual). |
One month after surgery | No |
Secondary | Change in vestibular function at middle term | Change in vestibular function (measured by means of videonystagmography) from baseline to 90 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests. Comparison between both groups (preoperative rehabilitation vs. usual). |
Three months after surgery | No |
Secondary | Change in vestibular function at long term | Change in vestibular function (measured by means of videonystagmography) from baseline to 365 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests. Comparison between both groups (preoperative rehabilitation vs. usual). |
One year after surgery | No |
Secondary | Preoperative change in vestibular function | Change in vestibular function (measured by means of videonystagmography) from baseline to three days before surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests. Comparison between both groups (preoperative rehabilitation vs. usual). |
From baseline to three days before surgery | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04196933 -
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
|
N/A | |
Active, not recruiting |
NCT00973739 -
Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
|
Phase 2 | |
Completed |
NCT04351373 -
Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560
|
Phase 2 | |
Active, not recruiting |
NCT01449604 -
Stereotactic Radiation in Vestibular Schwannoma
|
Phase 3 | |
Completed |
NCT01207687 -
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
|
Phase 2 | |
Not yet recruiting |
NCT05567341 -
Remote Ischemic Preconditioning in Vestibular Schwannoma Surgery
|
N/A | |
Completed |
NCT02249572 -
Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.
|
N/A | |
Terminated |
NCT05116878 -
Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma
|
N/A | |
Suspended |
NCT03095248 -
Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
|
Phase 2 | |
Recruiting |
NCT04801953 -
Nimodipine in Vestibular Schwanommas
|
Phase 2 | |
Recruiting |
NCT03745560 -
Intraoperative EABR for Decision Making
|
||
Recruiting |
NCT04859335 -
Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma
|
N/A | |
Recruiting |
NCT04128345 -
Novel Multimodality Imaging for Navigation in Skull Base Surgery
|
||
Active, not recruiting |
NCT01199978 -
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
|
Phase 2 | |
Recruiting |
NCT04057976 -
Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas
|
N/A | |
Completed |
NCT00863122 -
Concentration and Activity of Lapatinib in Vestibular Schwannomas
|
Early Phase 1 | |
Recruiting |
NCT04374305 -
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
|
Phase 2 | |
Recruiting |
NCT03079999 -
Study of Aspirin in Patients With Vestibular Schwannoma
|
Phase 2 | |
Recruiting |
NCT05786144 -
Vestibular Schwannoma Organoids
|
||
Recruiting |
NCT03593577 -
Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI
|